memory and dementia Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

what is dementia

A
  • Dementia - describes a collection of symptoms associated with impaired cognitive abilities and the ability to carry out day-to-day activities:
    • Memory loss
    • Difficulty sustaining attention
    • Language
    • Disorientation is space and time
    • Mood, social, and behavioural changes
      · Dementia is NOT a diagnosis in it’s own right but can be caused by a number of biological diseases.
  • Although dementia is more common in older adulthood, it is NOT a normal part of ageing.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how prevelant is dementia

A

· In the UK - 850,000 people estimated to be living with dementia, this is roughly 1 in 14 people over the age of 65 years.
· This figure is increasing -> 2 million people in the UK will have dementia by 2050.
· Alzheimer’s disease is the most common causes of dementia -> 60-70% cases.
- Other common pathologies include cerebrovascular disease and neocortical Lewy body disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

alzheimers disease

A

· Neurodegenerative disease - progressive, irreversible deterioration in cognitive abilities and daily function.
· In most people, symptoms of Alzheimer’s Disease appear after age 60.
· First discovered it by Alois Alzheimer, in the 1950s.
- This was due to a woman coming in Auguste D, she was diagnosed at 51.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

individual differences in symptom progression

A

· The way that a person experiences Alzheimer’s disease will depend on many factors, e.g., genes, physical health, personality and emotional resilience, the medication they take and the support they can rely on.
· Cognitive status over time for 9 participants followed over 5 years.
- Rusted and Sheppard, 2002

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

atrophy

A

· Neuronal loss, reduction in grey and white matter volume.
· Topographical progression: i) medial temporal lobe, ii) wider temporal regions, parietal and frontal areas, iii) widespread atrophy with visual and motor areas spared until late disease stages.
- Commonly looked at using structural magnetic resonance imaging.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hippocampal atrophy and memory

A

Brain slices showing gradual loss of hippocampal volume in people with Mild Cognitive impairment over 36 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

neurotransmitter production and function is impaired

A

· Synaptic dysfunction - altered communication between neurons.
· Loss of cell bodies in Nucleus Basalis of Meynert very early marker of Alzheimer’s.
· These cell bodies are involved in the production of acetylcholine (cholinergic neurotransmitter system).
- Medications to reduce dementia symptoms boost brain’s supply of acetylcholine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

measuring in vivo

A

· Quantification and localisation of amyloid and tau:
- Cerebrospinal fluid
- Bloods
- Positron emission tomography (PET) scans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

localisation of amyloid

A

· B-amyloid deposition first occurs in structures of the default mode network - the posterior cingulate cortex, precuneus, and medial prefrontal cortex.
- Associated with cognitive deficits and altered brain activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

localisation of tau

A

· Tau deposition follows Braak staging; localised to MTL in earliest stages of disease.
- Density of tau correlates better wit memory loss than amount of B-amyloid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

biomarker profile

A

· B-amyloid deposition can occur without clinical dementia.
- 25-30% of healthy older adults have diagnostically significant levels
- Co-occurrence of B-amyloid and abnormal tau deposits drive neurodegeneration and progression of Alzheimer’s Disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

lifespan approach

A

· Characterising risk - who is most at risk and why?
· Prevention - what actions can we take to manage risk of future neurodegeneration?
· Early detection- how do we spot individuals in the very earliest stages of Alzheimer’s Disease?
- Monitoring and lifestyle management - how does Alzheimer’s affect the lives of those living with dementia and what can we do to help?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what types of memory are affected

A

· Episodic memory - short and long term
· Semantic memory
· Working memory - flexibility of representations
· Spatial memory
- Lexicon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how do we assess memory impairment

A

· Benefits of in-clinical memory assessment: quick, easy-to administer, widespread adoption.
- Novel methods e.g., VR tests of spatial memory, smartphone-based measures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

targeting the cognitive functions most vulnerable to early change

A

· Mnemonic discrimination is the ability to encode and retrieve distinct memories from among events which share many common features.
- Memory tasks utilize perceptually and conceptually similar to test mnemonic discrimination or lure discrimination.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

mnemonic discrimination

A
  • Mnemonic discrimination errors:
    · Are increase in individuals with a diagnosis of Mild Cognitive Impairment.
    · Correlate with covert Alzheimer’s pathology in older adults without a diagnosis.
    · Are caused by altered brain function (proxied via fMRI BOLD response) in the memory regions of the medial temporal lobe.
    · As such, mnemonic discrimination tasks are a valuable tool for characterising mid-life risk.
  • Performance on this task is used as a tool for testing out new interventions.
17
Q

everyday life - tea making

A

· Multiple cognitive processes involved in even simple day to day tasks….
- Semantic memory - what makes tea?
- Spatial memory - where is the sugar?
- Autobiographic memory - dad likes two sugars?
- Working memory - what have I just done?
- Observation studies: a really important tool for a) learning how Alzheimer’s affects daily function, and b) thinking about how to promote independence for longer.

18
Q

everyday life - tea making 2

A

· Tea-making errors made by Stroke and Closed Head Injury patients:
- Omissions - failing to use milk
- Sequence - adding mil to kettle
- Substitution - stirring cup with a fork
- Additions - blending two routines
- Spatial - holding wrong end of spoon
- Other - quantity errors/task fail
· Rusted and Sheppard (2002) longitudinally monitored individuals living with dementia’s tea-making abilities over 5 years.
· Different approaches to measuring tea-making ability:
- Verbal description from memory
- Observation in own kitchen
- Observation in novel environment
- Instructing someone else how to make tea

19
Q

mean proportion of items recalled from own protocol

A

· Memories not lost, jumbled or fragmented; instead, difficult to access.
- Signpost for interventions: engage procedural memory, increase cues at transition points in routine.

20
Q

risk factors

A

· Challenge - how do we detect who will develop Alzheimer’s and when?
- Huge individual differences in the impact of normal ageing and neurodegenerative disease.

21
Q

our genes play a big role

A

· Deterministic genes are more closely tied to familial or early-onset Alzheimer’s. These account for <1% of cases.
- Chromosome 21, chromosome 14.
· Risk genes are associated with a higher incidence of Alzheimer’s but are not sufficient to cause it. Linked to ‘sporadic’ Alzheimer’s disease.
- Chromosome 19
- Polygenic risk

22
Q

APOE e4

A

· Associated with substantially greater risk of future Alzheimer’s disease and poorer cognitive ageing in healthy older adulthood.
- Cognitive, structural and functional brain differences from youth.

23
Q

summary

A

· Alzheimer’s is a biological disease, not just part of healthy ageing. The hallmark pathologies of Alzheimer’s (amyloid, tau and neurodegeneration) are observable prior to clinically relevant impairment.
· Memory deficits are a key component of dementia, but not at all. Developing novel assessment techniques, including observation of real-world behaviours, can allow us to diagnose the disease early, monitor symptoms, and improve the lives of people living with dementia.
- Age and genetic risk factors play a huge role in our likelihood of developing dementia. However, there are things we can do to reduce risk. Lifestyle and environmental changes can reduce risk for dementia by as much as 40%.